GLP-1 Weight Loss Blog

Tirzepatide has been studied in large-scale clinical trials involving thousands of patients. Here's what the safety data actually shows.

GLP-1 medications like semaglutide and tirzepatide are well-tolerated by most patients, but side effects do occur. Here's what to expect and how to manage them.

Tirzepatide and semaglutide are both highly effective GLP-1 medications for weight loss — but they work differently and produce different average results. Here's how to choose.

GLP-1 medications don't just cause weight loss — they have direct cardiovascular benefits backed by major clinical trials. Here's what the research shows.

Tirzepatide is powerful on its own — but the right strategies can significantly amplify your results. Here's how to get the most out of your program.

GLP-1 medications have specific FDA eligibility criteria. Here's exactly who qualifies, what conditions count, and what disqualifies patients from treatment.

Long-term GLP-1 weight loss is achievable — but it requires a thoughtful maintenance strategy. Here's what the research shows about sustained results.

Most patients notice tirzepatide working within the first 1-2 weeks. Here's the full timeline from first dose to peak results, based on clinical data.

Muscle loss is a concern with any significant weight loss — including GLP-1 therapy. Here's what the research shows and how to protect your muscle mass.

In most patients, tirzepatide is administered by injection under the skin once a week. The dosage is increased over 20 weeks to bring on results, per the FDA. However, dosage may be adjusted to people’s specific needs, depending on their goals and othe...